A research team from Finland studied whether high-sensitivity C-reactive protein (hs-CRP) measurement can aid the assessment of disease activity and glucocorticoid treatment in paediatric inflammatory bowel disease (IBD). Their study showed that the measurement of hs-CRP did not prove useful in the assessment of disease activity or glucocorticoid treatment in pediatric IBD patients that had undetectable standard CRP.